Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2012. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to reporting specific share transactions and does not contain financial statements or performance metrics.
Material Changes
The filing details the acquisition of Ordinary shares by several executives on January 11, 2012, through the Company's Share Reward Plan. The purchase price was 1,435.17 pence per share. Transactions included both personal contributions and matching company contributions:
- Sir Andrew Witty: Acquired 9 shares (personal) and 9 shares (company match).
- Mr S Dingemans: Acquired 9 shares (personal) and 9 shares (company match).
- Mr S M Bicknell: Acquired 9 shares (personal) and 9 shares (company match).
- Mr E J Gray: Acquired 9 shares (personal) and 9 shares (company match).
- Mr D S Redfern: Acquired 9 shares (personal) and 9 shares (company match).
- Ms C Thomas: Acquired 9 shares (personal) and 9 shares (company match).
- Mr P C Thomson: Acquired 7 shares (personal) and 7 shares (company match).
- Dr P J T Vallance: Acquired 9 shares (personal) and 9 shares (company match).
- Mrs V A Whyte: Acquired 9 shares (personal) and 9 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document strictly adheres to the notification requirements of Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Share price at the time of transaction was 1,435.17 pence per Ordinary share.
- Transactions were executed on January 11, 2012, and notified on January 12, 2012.
- Acquisitions were made under the Company's Share Reward Plan, involving both personal and company-matching contributions.
- The filing contains no financial performance data for the period.